-
Sex, gender and clinical research: have you considered the possibilities?
Joy Johnson
Editorial: Clinical Investigation
-
Sex, gender and clinical research: have you considered the possibilities?
Joy Johnson
Editorial: Clinical Investigation
-
Sex, gender and clinical research: have you considered the possibilities?
Joy Johnson
Editorial: Clinical Investigation
-
Sex, gender and clinical research: have you considered the possibilities?
Joy Johnson
Editorial: Clinical Investigation
-
Sex, gender and clinical research: have you considered the possibilities?
Joy Johnson
Editorial: Clinical Investigation
-
Sex, gender and clinical research: have you considered the possibilities?
Joy Johnson
Editorial: Clinical Investigation
-
Sex, gender and clinical research: have you considered the possibilities?
Joy Johnson
Editorial: Clinical Investigation
-
Sex, gender and clinical research: have you considered the possibilities?
Joy Johnson
Editorial: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
Arformoterol: rationale for use in chronic obstructive pulmonary disease
Jordan Terasaki, Shawn PE Nishi, Bill T Ameredes & Gulshan Sharm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Arformoterol: rationale for use in chronic obstructive pulmonary disease
Jordan Terasaki, Shawn PE Nishi, Bill T Ameredes & Gulshan Sharm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Arformoterol: rationale for use in chronic obstructive pulmonary disease
Jordan Terasaki, Shawn PE Nishi, Bill T Ameredes & Gulshan Sharm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Arformoterol: rationale for use in chronic obstructive pulmonary disease
Jordan Terasaki, Shawn PE Nishi, Bill T Ameredes & Gulshan Sharm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Arformoterol: rationale for use in chronic obstructive pulmonary disease
Jordan Terasaki, Shawn PE Nishi, Bill T Ameredes & Gulshan Sharm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Arformoterol: rationale for use in chronic obstructive pulmonary disease
Jordan Terasaki, Shawn PE Nishi, Bill T Ameredes & Gulshan Sharm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Arformoterol: rationale for use in chronic obstructive pulmonary disease
Jordan Terasaki, Shawn PE Nishi, Bill T Ameredes & Gulshan Sharm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Arformoterol: rationale for use in chronic obstructive pulmonary disease
Jordan Terasaki, Shawn PE Nishi, Bill T Ameredes & Gulshan Sharm
Review: Clinical Trail Outcomes: Clinical Investigation
-
New strategies for the treatment of inflammatory bowel diseases
Xavier Roblin, William Dronne, Stephane Paul, Emilie Del Tedesco
Review: Clinical Trail Outcomes: Clinical Investigation
-
New strategies for the treatment of inflammatory bowel diseases
Xavier Roblin, William Dronne, Stephane Paul, Emilie Del Tedesco
Review: Clinical Trail Outcomes: Clinical Investigation
-
New strategies for the treatment of inflammatory bowel diseases
Xavier Roblin, William Dronne, Stephane Paul, Emilie Del Tedesco
Review: Clinical Trail Outcomes: Clinical Investigation
-
New strategies for the treatment of inflammatory bowel diseases
Xavier Roblin, William Dronne, Stephane Paul, Emilie Del Tedesco
Review: Clinical Trail Outcomes: Clinical Investigation
-
New strategies for the treatment of inflammatory bowel diseases
Xavier Roblin, William Dronne, Stephane Paul, Emilie Del Tedesco
Review: Clinical Trail Outcomes: Clinical Investigation
-
New strategies for the treatment of inflammatory bowel diseases
Xavier Roblin, William Dronne, Stephane Paul, Emilie Del Tedesco
Review: Clinical Trail Outcomes: Clinical Investigation
-
New strategies for the treatment of inflammatory bowel diseases
Xavier Roblin, William Dronne, Stephane Paul, Emilie Del Tedesco
Review: Clinical Trail Outcomes: Clinical Investigation
-
New strategies for the treatment of inflammatory bowel diseases
Xavier Roblin, William Dronne, Stephane Paul, Emilie Del Tedesco
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma
Krishan Jethwa, Jun Wei, Kayla McEnery,Amy B Heimberger
Patient Perspective: Clinical Investigation
-
miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma
Krishan Jethwa, Jun Wei, Kayla McEnery,Amy B Heimberger
Patient Perspective: Clinical Investigation
-
miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma
Krishan Jethwa, Jun Wei, Kayla McEnery,Amy B Heimberger
Patient Perspective: Clinical Investigation
-
miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma
Krishan Jethwa, Jun Wei, Kayla McEnery,Amy B Heimberger
Patient Perspective: Clinical Investigation
-
miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma
Krishan Jethwa, Jun Wei, Kayla McEnery,Amy B Heimberger
Patient Perspective: Clinical Investigation
-
miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma
Krishan Jethwa, Jun Wei, Kayla McEnery,Amy B Heimberger
Patient Perspective: Clinical Investigation
-
miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma
Krishan Jethwa, Jun Wei, Kayla McEnery,Amy B Heimberger
Patient Perspective: Clinical Investigation
-
miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma
Krishan Jethwa, Jun Wei, Kayla McEnery,Amy B Heimberger
Patient Perspective: Clinical Investigation
-
Gender differences and clinical trial design
Sabine Oertelt-Prigione
Editorial: Clinical Investigation
-
Gender differences and clinical trial design
Sabine Oertelt-Prigione
Editorial: Clinical Investigation
-
Gender differences and clinical trial design
Sabine Oertelt-Prigione
Editorial: Clinical Investigation
-
Gender differences and clinical trial design
Sabine Oertelt-Prigione
Editorial: Clinical Investigation
-
Gender differences and clinical trial design
Sabine Oertelt-Prigione
Editorial: Clinical Investigation
-
Gender differences and clinical trial design
Sabine Oertelt-Prigione
Editorial: Clinical Investigation
-
Gender differences and clinical trial design
Sabine Oertelt-Prigione
Editorial: Clinical Investigation
-
Gender differences and clinical trial design
Sabine Oertelt-Prigione
Editorial: Clinical Investigation